Annals of Urologic Oncology (AUO, Ann Urol Oncol, p-ISSN: 2617-7765, e-ISSN: 2617-7773), publishes the results of novel research in the laboratory and clinical settings, including risk assessment, cellular and molecular characterization, prevention, detection, diagnosis and treatment of human urologic oncology with the overall goal of improving clinical care of patients with urologic tumours. It includes three main subjects: bladder, prostate and kidney cancer. In addition, adrenal tumor, testicular cancer, and carcinoma of penis are also considered for the journal subjects.
Indexing Google Scholar, ResearchGate, DOAJ
Current Issue Volume 7 Issue 4, 2024 >>
Editorial board
Editors-in-Chief:
Bladder cancer is among most common malignancies worldwide, with significant morbidity and mortality. Conventional treatment strategies for bladder ca ...
Beatriz Ramos, Dakota Rogers
REVIEW | 05 Feb 2025
Prostate cancer is a worldwide health concern in men, with substantially high incidence rate and advanced metastatic disease-related mortality rates. ...
Ali Usman
REVIEW | 31 Jan 2025
Renal cell carcinoma (RCC) accounts for approximately 2.2% of all diagnosed cancers and 1.8% of cancer-related deaths. Clear cell renal cell carcinoma ...
Daniel Chikere Ali, Siva Bharath Merugu
REVIEW | 29 Jan 2025
Prostate cancer (Pca) is a significant malignancy affecting men's health, with its incidence steadily increasing worldwide in recent years. Among its ...
Haq Dad, Asger Hansen
REVIEW | 27 Dec 2024
Extirpative bladder surgery for bladder cancer requires urinary diversion which causes cosmetic and functional changes that affect a patient’s body im ...
Ava Saidian, Hannah G Hingtgen ... Amirali Salmasi
RESEARCH | 13 Oct 2024
Bladder cancer is a complex disease with distinct treatment approaches based on its progression. For non-muscle invasive bladder cancer, the primary t ...
Clara Joseph
REVIEW | 13 Nov 2024